Floatz logo

ONGROSTAB HMB

UV Ray Skin Damage

Yale UniversitySmall moleculePhase 1Dormant
CC
47/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
32/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the UV Ray Skin Damage cohort.

Asset / SponsorPhaseRating
PADIMATE O
Yale University
Phase 1CC

Same molecule, other indications

ONGROSTAB HMB is also rated in:

MelanomaDormant
CC
Indicative ·
40 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →